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Disparities in the management of ST-elevation myocardial infarction (STEMI) undermine the 
opportunity to reduce the global burden of cardiovascular disease
1
. Timely reperfusion 
therapy, preferably with primary percutaneous coronary intervention (PCI), as well as 
attainment to guideline-indicated care and secondary prevention measures reduce STEMI 
morbidity and mortality
2
. Clinical registries play an important role in identifying gaps in 
STEMI care, regional variations in practice, and opportunities for improvement
3
. 
Furthermore, registries enable the evaluation of the differences in STEMI management 
between countries, which may help improve the prognosis following STEMI
4
.   
 
International comparisons research using registry data, however, is constrained by the 
heterogeneity between existing registries
5
. For instance, countries, such as Sweden and the 
UK, have established national STEMI registries, yet studies comparing STEMI care and 
outcomes between Sweden and the UK were not facilitated by the differences in their 
respective registries’ design, completeness, and coverage4. Across the Asian-Pacific region, 
where population is diverse and both economic and healthcare systems are at different 






. used already published data from twenty STEMI registries in 5 Asia-Pacific 
countries to compare STEMI care and mortality between these countries. In total, 158420 
patients from Australia, Japan, Korea, Singapore and Malaysia, whom data were collected 
after the year 2000, were included in this meta-analysis. The authors described patient 






































































































and 1-year mortality rates. The analysis was supplemented by public health data and 
clinician-report surveys to evaluate systems of care in each of the 5 countries.  
 
Tern et al . found that whilst national STEMI registries were available in all countries apart 
from Australia, only Singapore’s was compulsory and recorded ‘all-comers’ STEMI patients. 
In addition, both within and between country variability across the selected registries was 
observed, with differences in data variables definitions, registry methodology, and inclusion 
criteria. Such variability may have contributed to the differences in STEMI outcomes 
between countries. For instance, unlike other registries, the Singapore Myocardial Infarction 
Registry included patients who had died out of-hospital or in the emergency department, 
which may explain why higher STEMI mortality rates were seen in Singapore.   
 
Nonetheless, pooled estimates of data allowed the reviewers to conduct meaningful 
comparisons between the 5 countries. They reported that different countries had different 
STEMI patient demographics and co-morbidities. A finding that have been previously 
reported both within and outside the Asia-Pacific region
6
, and reflect the geographical 
differences in acute myocardial infarction (AMI) patient profile. In Europe in particular, 
substantial variation in patient characteristics has been observed between Central, Eastern, 
Western, and Northern countries
1
.   
 
The authors concluded that, notwithstanding the 5 countries had similar development and 
public health indices, there were significant variations in STEMI management and mortality 
rates. One of the most striking variation in care delivery for STEMI patients was the 






































































































over 90% to around 9% in Korea and Malaysia, respectively. The other 3 countries had 
primary PCI rates comparable to these observed in Europe
1
. These figures were matched 
with variations in thrombolysis rates across the 5 countries, with highest rates in Malaysia 
(72.6%) and lowest in Singapore (1.1%).  
 
In addition to the variation in reperfusion treatment, different countries had variable 
adherence to secondary prevention medications following STEMI. The appropriate use of 
such medications has been shown to improve outcomes
2
, and is proposed as an indicator of 
care quality
8
. However, to assess the appropriateness of care, data that are both reliable 
and sufficient, including potential exceptions (e.g., contraindication)
9
, are needed. Thus, it is 
imperative for clinical registries to capture high-quality data about important processes of 
STEMI care to allow the distinction between good and poor practice.  
 
The reviewers reported that Malaysia and Singapore had higher mortality rates from STEMI 
than the other 3 countries. They explained that this could be attributed to the wide 
inclusion criteria of the STEMI registry in Singapore, the lower use of primary PCI in 
Malaysia, and/or the greater ethnic diversities in these 2 countries. Although it is difficult to 
infer causation from observational data, similar association between high reliance on 
thrombolysis therapy for STEMI and increased mortality rates was observed in Eastern 
European countries
1
. However, when using an outcome measure for benchmarking, 
differences may be due to factors other than quality of care (e.g., case-mix)
10
, which need 







































































































Mapping the geographical differences in STEMI presentation, management, and outcomes is 
critical to address gaps in care delivery
1
. For the Asian-Pacific region and beyond, 
nationwide registries are integral to quality improvement initiatives
11
. As such, quality 
indicators that are developed methodologically
9
, can be implemented within registries to 
measure performance
12
 and disparities in care provision
13
. Future registries, such as the 
European Unified Registries On Heart Care Evaluation and Randomized Trials (EuroHeart), 
will use harmonized data standards and provide a unified platform for continuous data 
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